About Tillotts pharma ag
Tillotts Pharma AG is a leading specialty pharmaceutical company that has been making waves in the industry for its innovative and effective products. With a team of approximately 300 employees worldwide, Tillotts is dedicated to improving the lives of patients suffering from gastrointestinal (GI) diseases.
Founded in 1950, Tillotts has come a long way since its inception. The company's mission is to develop and market innovative medicines that address unmet medical needs in the field of gastroenterology. Over the years, Tillotts has built an impressive portfolio of products that are used by healthcare professionals around the world.
One of Tillotts' flagship products is Asacol® HD (mesalamine), which is used to treat ulcerative colitis. This medication works by reducing inflammation in the colon and rectum, thereby relieving symptoms such as diarrhea, abdominal pain, and rectal bleeding. Asacol® HD has been shown to be safe and effective in clinical trials, making it a popular choice among physicians.
Another product that Tillotts offers is Entocort® EC (budesonide), which is used to treat Crohn's disease. This medication works by reducing inflammation in the small intestine and colon, thereby relieving symptoms such as abdominal pain, diarrhea, and weight loss. Entocort® EC has also been shown to be safe and effective in clinical trials.
In addition to these medications, Tillotts also offers a range of other products for GI diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome (IBS), and more. These include Colpermin®, Octasa®, Simtomax®, VSL#3®, among others.
Tillotts' success can be attributed not only to its innovative products but also its commitment to quality assurance. The company adheres strictly to international standards for manufacturing processes and quality control systems. This ensures that all their products meet high standards of safety, efficacy, and quality.
Tillotts is also committed to sustainability and social responsibility. The company has implemented various initiatives to reduce its environmental impact, such as reducing waste and energy consumption. Additionally, Tillotts supports various charitable organizations that work towards improving the lives of patients with GI diseases.
In conclusion, Tillotts Pharma AG is a fast-growing specialty pharmaceutical company that has made significant contributions to the field of gastroenterology. With its innovative products, commitment to quality assurance, and dedication to sustainability and social responsibility, Tillotts is poised for continued success in the years ahead.